Cell and gene therapies require the very highest levels of quality, so an effective fill-finish solution is essential to manufacturing operations.

The Pistoia Alliance have announced their plans to develop a toolkit to help companies navigate large datasets.

Dutch authorities hand over the keys to the EMA's new building in Amsterdam.

The UK’s “sovereignty” debate does not end with an agreed UK-EU relationship. It extends to all trading partners...

Hovione’s New Jersey-based site has provided process development and small volume API manufacturing since 2002.

The reported benefits of continuous manufacturing for small molecules over batch manufacturing include accelerated product and process development.

The economic and technological advantages of continuous flow chemistry are driving adoption by API manufacturers.

Small molecules continue to play a significant role in the development of innovative treatments.

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."

More complex proteins are coming down the pipe! Next-generation protein expression will require a toolbox of next-generation solutions.